Novartis Ag (NVSEF) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to -$11.6 billion.
- Novartis Ag's Enterprise Value rose 1387.38% to -$11.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$11.6 billion, marking a year-over-year increase of 1387.38%. This contributed to the annual value of -$11.6 billion for FY2025, which is 1387.38% up from last year.
- Latest data reveals that Novartis Ag reported Enterprise Value of -$11.6 billion as of Q4 2025, which was up 1387.38% from -$9.6 billion recorded in Q3 2025.
- In the past 5 years, Novartis Ag's Enterprise Value ranged from a high of -$5.0 billion in Q1 2022 and a low of -$6000.3 billion during Q1 2021
- Its 5-year average for Enterprise Value is -$312.6 billion, with a median of -$11.9 billion in 2023.
- As far as peak fluctuations go, Novartis Ag's Enterprise Value plummeted by 115158445.3% in 2021, and later surged by 9991.61% in 2022.
- Novartis Ag's Enterprise Value (Quarter) stood at -$28.3 billion in 2021, then skyrocketed by 33.18% to -$18.9 billion in 2022, then increased by 23.78% to -$14.4 billion in 2023, then increased by 6.73% to -$13.5 billion in 2024, then increased by 13.87% to -$11.6 billion in 2025.
- Its Enterprise Value was -$11.6 billion in Q4 2025, compared to -$9.6 billion in Q3 2025 and -$7.0 billion in Q2 2025.